TRINETRA › Sectors › Consumer Services
Medplus Health Services Limited (MEDPLUS) — share price, P/E and fundamentals
Medplus Health Services Limited (NSE: MEDPLUS) closed at ₹579.90 on 30 Oct 2026, -24.0% over one year, against a 52-week range of ₹565.60 – ₹1,022.20.
In the quarter ended 30 Sept 2026 (consolidated, filed 27 Oct 2026) it reported revenue of ₹2,037 cr and net profit of ₹56 cr, a 2.8% net margin; revenue grew 21.3% and profit grew 1.8% year on year.
On four consecutive filed quarters its trailing P/E is 33.0; since 27 May 2025 its own P/E has ranged from 32.9 to 77.3 (median 52.0), and today's reading is higher than 0% of those 353 trading days.
From the balance sheet dated 30 Sept 2026: return on equity 10.8%, ROCE 12.5%, debt-to-equity 0.00, Piotroski F-score 7 of 9.
Against 40 Consumer Services peers on NSE: Net margin higher than 30% of 40 sector peers; PBT margin higher than 28% of 40 sector peers; ROE higher than 58% of 40 sector peers.
Key figures
| Last close | ₹579.90 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -11.4% / -35.8% / -24.0% |
| 52-week low – high | ₹565.60 – ₹1,022.20 |
| Market capitalisation | ₹6,967 cr |
| Trailing P/E | 33.0 |
| Price / book | 3.37 |
| EV / EBITDA | 9.6 |
| Earnings yield | 3.0% |
| TTM EPS | ₹17.57 |
| TTM net profit | ₹211 cr |
| Quarter revenue | ₹2,037 cr |
| Quarter net profit | ₹56 cr |
| Net margin | 2.8% |
| Revenue growth (YoY) | +21.3% |
| Profit growth (YoY) | +1.8% |
| Return on equity | 10.8% |
| ROCE | 12.5% |
| Debt / equity | 0.00 |
| Current ratio | 2.83 |
| Free cash flow | ₹85 cr |
| Piotroski F-score | 7 / 9 |
| Average daily turnover (50 days) | ₹5.8 cr |
Against Consumer Services peers
| Metric | MEDPLUS | Peer median | Percentile |
|---|---|---|---|
| Net margin | 2.75 | 5.98 | 30 |
| PBT margin | 3.44 | 8.62 | 28 |
| ROE | 10.84 | 9.32 | 58 |
| ROCE | 12.45 | 12.16 | 53 |
| Debt / equity | 0.00 | 0.11 | 20 |
| FCF margin | 2.16 | 10.95 | 31 |
| Cash conversion | 1.82 | 1.28 | 64 |
| Trailing P/E | 33.01 | 51.99 | 28 |
Questions
What is the P/E ratio of Medplus Health Services Limited?
Medplus Health Services Limited's trailing P/E is 33.0, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 27 May 2025 its P/E has ranged 32.9–77.3.
What were Medplus Health Services Limited's latest quarterly results?
For the quarter ended 30 Sept 2026, Medplus Health Services Limited reported revenue of ₹2,037 cr and net profit of ₹56 cr (consolidated), filed with the exchange on 27 Oct 2026.
What is Medplus Health Services Limited's ROE?
Return on equity is 10.8% based on the balance sheet dated 30 Sept 2026.
Does Medplus Health Services Limited have debt?
Debt-to-equity is 0.00 on the balance sheet dated 30 Sept 2026.
What is MEDPLUS's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, MEDPLUS traded between ₹565.60 and ₹1,022.20.
Other Consumer Services stocks
- ETERNAL LIMITED (ETERNAL)
- Avenue Supermarts Limited (DMART)
- Trent Limited (TRENT)
- Lenskart Solutions Limited (LENSKART)
- The Indian Hotels Company Limited (INDHOTEL)
- Meesho Limited (MEESHO)
- FSN E Commerce Ventures Limited (NYKAA)
- Info Edge (India) Limited (NAUKRI)
- Swiggy Limited (SWIGGY)
- Vishal Mega Mart Limited (VMM)
- Physicswallah Limited (PWL)
- Indian Railway Catering And Tourism Corporation Limited (IRCTC)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Sept 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.